Camile Farah
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Camile Farah
Chief Executive Officer, Managing Director / Optiscan Imaging
Most Notable Role
Professor Camile Farah is an executive, academic, researcher and author with over 25 years of experience in the healthcare, biotech and medical research sectors.
Prof Farah is a clinician scientist and has experience in various optical imaging technologies, clinical practice and medtech research. He is dual trained physician and pathologist, with public and private appointments at Fiona Stanley Hospital, Hollywood Private Hospital, Qscan Radiology Clinics, Australian Clinical Labs, and Genomics for Life.
Prof Farah is an Australian executive in oral cancer and precancerous pathology, having published 250 clinical and scientific articles and a bestselling textbook.
He was Dean at the University of Western Australia, and is an Adjunct Professor at CQ University and an Honorary Professorial Research Fellow at the Peter MacCallum Cancer Centre.
In addition to managing his own consulting business, Prof Farah is also an executive director of the Australian Centre for Oral Oncology Research & Education which undertakes cutting edge research in head and neck cancer.
Prof Farah is a clinician scientist and has experience in various optical imaging technologies, clinical practice and medtech research. He is dual trained physician and pathologist, with public and private appointments at Fiona Stanley Hospital, Hollywood Private Hospital, Qscan Radiology Clinics, Australian Clinical Labs, and Genomics for Life.
Prof Farah is an Australian executive in oral cancer and precancerous pathology, having published 250 clinical and scientific articles and a bestselling textbook.
He was Dean at the University of Western Australia, and is an Adjunct Professor at CQ University and an Honorary Professorial Research Fellow at the Peter MacCallum Cancer Centre.
In addition to managing his own consulting business, Prof Farah is also an executive director of the Australian Centre for Oral Oncology Research & Education which undertakes cutting edge research in head and neck cancer.
Lists and Charts
Total Shareholder Return as at 29/11/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 207th | Optiscan Imaging | 70% | 31% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Optiscan Imaging | $3.0m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Clinical Co-Director, Maxillofacial Pathologist, Clinical Labs | 12 May 2021 |
| NEW ROLE: Senior Staff Specialist, Oral Medicine & Oncology, Fiona Stanley Hospital | 12 May 2021 |
| NEW ROLE: Specialist, Oral Medicine & Oral Pathology, Hollywood Private Hospital | 12 May 2021 |
| NEW ROLE: Chief Executive Officer, Managing Director, Optiscan Imaging | 12 May 2021 |
